Jeff Coller is the Bloomberg Distinguished Professor of RNA Biology and Therapeutics at Johns Hopkins University.
Coller’s lab has made seminal discoveries in the area of messenger RNA stability and translation.
He studies the very essence of life: translation of the genetic code. His work has led to fundamental shifts in the understanding of gene expression by demonstrating that the genetic code is a major determinant of mRNA fate. He is the co-founder of Tevard Biosciences and WyveRNA Therapeutics. In 2018, Tevard Biosciences was awarded Pfizer’s Golden Ticket award for promising neuroscience startups.
He received his PhD in cellular and molecular biology from the University of Wisconsin and was a postdoctoral fellow in the Howard Hughes Medical Institute at the University of Arizona. Prior to moving to Johns Hopkins University, Coller served as director of the RNA Center at Case Western Reserve University where he held the Henry Willson Payne Distinguished Professorship. His publications have been cited over 6,000 times, and he currently holds numerous patents for RNA-based therapeutic applications.